Article
Establishment of hepatitis C virus RNA-replicating cell lines possessing ribavirin-resistant phenotype.
PloS one - 1 Jan 2015
Satoh Shinya, Mori Kyoko, Ueda Youki, Sejima Hiroe, Dansako Hiromichi, Ikeda Masanori, Kato Nobuyuki
Abstract excerpt
BACKGROUND: Ribavirin (RBV) is a potential partner of interferon-based therapy and recently approved therapy using direct acting antivirals for patients with chronic hepatitis C. However, the precise mechanisms underlying RBV action against hepatitis C virus (HCV) replication are not yet understo...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
